Therapeutic potential of anticoagulant therapy in association with cytokine storm inhibition in severe cases of COVID-19: A case report
Inflammation and coagulation are considered to the development of Coronavirus disease 2019 (COVID-19)-related hypoxemia. However, this is still controversial, which brings challenges to clinical treatment. Here, we reviewed the levels of interleukin-6 (IL-6), coagulation indexes, and clinical manife...
Guardado en:
Autores principales: | Xu Qiancheng, Wang Tao, Lu Weihua |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
De Gruyter
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b3dda005a6c1475fb8f32cbf7445c68a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pentoxifylline as a Potential Adjuvant Therapy for COVID-19: Impeding the Burden of the Cytokine Storm
por: Wiktoria Feret, et al.
Publicado: (2021) -
Effectiveness of Tocilizumab with and without Dexamethasone in Patients with Severe COVID-19: A Retrospective Study
por: Zarębska-Michaluk D, et al.
Publicado: (2021) -
Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19
por: Hayder M. Al-kuraishy, et al.
Publicado: (2021) -
Attenuating the Effects of Novel COVID-19 (SARS-CoV-2) Infection-Induced Cytokine Storm and the Implications
por: Rowaiye AB, et al.
Publicado: (2021) -
Roles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target?
por: Kavya Srinivasan, et al.
Publicado: (2021)